On Thursday, the Houston Comets unveiled a new brand identity. According to a team announcement, the release "represents a defining moment in the return of one of the most iconic franchises in women's sports."
Revealed during a celebration at POST Houston, the new identity marks the beginning of the Comets' next chapter. The evening brought together Comets legends, fans, partners, and community leaders for a first look at the franchise's new era, and it all culminated with the unveiling of the team's new logo.
As the Comets prepare to return to the court in 2027, the brand identity honors the franchise's historic championship legacy while also introducing a bold, modern look for a new generation of fans.
One of the WNBA's original eight franchises, the Comets established the league's first dynasty by winning four consecutive championships from 1997 through 2000. The brand identity pays homage to that foundation while looking ahead to the new era of the team and its connection to its fans.
"This is a landmark moment for the Comets, for Houston, and for the continued growth of women's sports," said Gretchen Sheirr, president of business operations for the Houston Rockets and Comets. "This franchise helped define the early years of the WNBA, and we are incredibly proud to honor that championship history while building something modern, bold, and distinctly Houston for the future."

#houston #identity #team #moment

The fallout from Kylian Mbappé's comments about a meme depicting Mao Zedong has extended into football video games in China, while the creator of the original montage has spoken about the reaction. On the pitch, Madrid continued preparing for Sunday's visit to Racing Santander, with Arda Güler and Fede Valverde following individual programs. Carlo Ancelotti also announced his latest Brazil squad, calling up Vinícius Júnior and Endrick but leaving Éder Militão out.
The commercial consequences of Mbappé's remarks now include measures affecting Chinese versions of FC Online and Konami's eFootball-related ******* les. Reports citing announcements on the games' local channels describe the removal of promotional material and restrictions on content featuring the Madrid forward.
FC Online said it had begun removing Mbappé-related content from external channels and would implement further changes through an update. The Chinese versions of the Konami ******* les also announced measures covering promotion of the player and the characters or cards ******* ociated with him. The reported action concerns the Chinese editions, rather than a worldwide removal from the franchises.
The measures follow the termination of Mbappé's partnerships with Dongpeng, Mengniu and Milkground, alongside China Media Group's suspension of LaLiga broadcasts and other programming involving the player.
Real Madrid's apology has not ended scrutiny of the club's handling of the controversy. Chinese state-linked outlets and official platforms have questioned the timing of its response and called for measures beyond a public statement. Mbappé apologized on October 27, with Madrid issuing its own apology on October 28.

#announced

AA Milne's first Pooh book was published a century ago in October 1926. Generations of children loved it, but its inspiration, the author's own son, told the BBC that he took to "running away when people bring up the subject".
"Pooh, promise you won't forget about me, ever. Not even when I'm a hundred." This is the plaintive cry made by Christopher Robin to his teddy bear, Winnie-the-Pooh, in the final chapter of The House in Pooh Corner.
British novelist and playwright AA Milne needn't have worried. The first Winnie-the-Book was published 100 years ago in October 1926, and introduced a cast of characters modelled on the author's son and the soft toys he played with: lovably dim Pooh Bear, nervy Piglet, hyperactive Tigger, pessimistic Eeyore. Far from being forgotten, in the century since then the characters have taken on a life far beyond the parameters of their idyllic home, the Hundred Acre Wood.
BBC Radio 4, Desert Island Discs: Christopher Milne, 13/11/1976
From 1966, they became the subject of animated and live-action Disney films, in what is now one of the highest-grossing media franchises of all time. Pooh Bear has even courted controversy in Poland for being "inappropriate", sparked memes mocking the Chinese president Xi Jinping, and prompted tongue-in-cheek pop-culture theories in which the residents of the Hundred Acre Wood have been "diagnosed" with different psychological conditions.

#christopher #acre #wood

The goal that pushed the Minnesota Wild past the Blue Jackets in a 2-1 win Oct. 18 at Grand Casino Arena was shot into an opening roughly the size of a basketball above goalie Cam Talbot's shoulder during a power play in the second period.
More: Columbus Blue Jackets stumble in 2-1 loss to Minnesota Wild
The guy who sent it there, Kirill Kaprizov, leads the NHL with 10 goals in nine games and makes $17 million a season. There wasn't much Talbot could've done, even with an unobstructed view of Kaprizov's shot, but the veteran backstop wore it anyway.
"Yeah, I think I gave him a little bit too much [to shoot at]," Talbot said. "He put it in a great spot, but the other four guys are doing their job. That's my guy. I've got to make that save."
Talbot's answer plus his impressive ability to remain solid into his upper 30s is how he became the first goalie in NHL history to play and win games for nine separate franchises during his Blue Jackets debut Oct. 9 in a victory over the Pittsburgh Penguins. He was the least of the Jackets' concerns in St. Paul, Minnesota, where the Wild forced him to make 32 saves to keep it a one-goal differential.

#goal #shot #play

When Kawhi Leonard became a Toronto Raptor for the first time in the summer of 2018, he looked shellshocked. "There's just more questions you have to ask me in order for me to tell you about myself," he said, introducing himself to an organization and city he reportedly had no interest in joining.
Leonard had fallen out with his former team, the San Antonio Spurs – one of the most respected franchises in professional sports – due to differences in opinion about an injury that had limited him to just nine games in the 2017-18 season. The Los Angeles native had hoped to end up in southern California, but instead the Raptors risked it all by swapping franchise cornerstone DeMar DeRozan for one year of an injured, malcontent Leonard. It worked: Leonard led the Raptors to their maiden championship on the back of a historic playoff run, averaging 30.5 points, 9.1 rebounds, 3.9 **** ists and 1.7 steals en route. Leonard won his second finals MVP to go alongside the one he had claimed with the Spurs when he helped them to the **** le in 2014.
Related: LeBron James is everything Philadelphia wants. And everything it can't stand | Bryan Armen Graham
"The narrative of not wanting to come to this city is gone," the team's president, Masai Ujiri, said at that 2018 press conference, speaking to insecure Raptors fans who had watched American players like Vince Carter, Tracy McGrady, and Chris Bosh leave Toronto since the franchise opened its doors in 1995. "We should move past that. Believe in this city. Believe in yourselves … We are proud of who we are."
But even a historic season wasn't enough to convince Leonard to stay north of the border. After a long and contentious free-agency period managed by his uncle, Dennis Robertson, Leonard spurned the reigning champions in favor of his hometown Los Angeles Clippers. "There wasn't as much anger in 2019 as there was with Vince Carter or some of the other guys who left," says Bruce Arthur, who has covered Leonard since 2018 for the Toronto Star. "I think he was given a little bit of special dispensation because he was going home, because he had delivered a **** le, and because I never felt like there was ever a connection outside of Kawhi the basketball player, with Toronto."

#SPURS #vince #carter #believe

McDonald's is facing a federal lawsuit that alleges its AI-enhanced pricing tool violates antitrust laws because it shares nonpublic data with franchisees who might be competing in the same market.
The lawsuit, which was filed Friday in Illinois, said McDonald's pricing tool uses artificial intelligence to collect data that competing franchises wouldn't normally share, like store-level sales. The Chicago-based burger giant has said it makes the tool available to U.S. franchisees to help them set prices at their individual restaurants.
The lawsuit also blames the pricing system for raising McDonald's U.S. prices.
"McDonald's has built and for years deployed its own information-sharing pricing platform, which draws on data from its millions of daily transactions to set menu prices across thousands of U.S. restaurants," the lawsuit states. "The result is algorithmic price-fixing aimed at customers who are already stretched thin."
McDonald's said Tuesday that the lawsuit is "filled with inaccuracies" and it would vigorously defend itself.

#restaurants

In late September 2026, AT&S Austria Technologie & Systemtechnik AG announced an expanded collaboration with Marvell Technology to increase advanced IC substrate capacity for next-generation AI and cloud infrastructure, while Marvell also affirmed a quarterly dividend of US$0.06 per share payable on October 29, 2026.
This deeper manufacturing partnership gives Marvell greater access to complex packaging technologies that are increasingly critical for high-performance AI chips and data center hardware.
Next, we'll examine how this expanded AT&S manufacturing capacity could influence Marvell's AI-focused growth story and longer-term investment narrative.
The future of work is here. Discover the 89 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
To own Marvell, you need to believe its AI and data center franchises can justify today's rich valuation and eventually translate into stronger, more consistent earnings power. The expanded AT&S IC substrate deal directly supports Marvell's near term AI optics and custom silicon ramp, while also amplifying the existing risk that long term supplier prepayments and capacity commitments could weigh on margins and free cash flow if AI demand or customer ramps slow.

#term #substrate #Manufacturing #data

The $110 billion merger of Paramount Skydance and Warner Bros. Discovery closed on Tuesday after Supreme Court Justice Elena Kagan denied a last-minute effort to halt the deal.
The new company — known as Skydance (SKYD)— brings the HBO Max and Paramount+ streaming services under one umbrella, roughly seven months after Paramount won a long bidding war with Netflix (NFLX) for Warner Bros.
The merger faced plenty of pushback and a long road to closing.
"The completed transaction unites two of media and entertainment's most storied companies, each with a history spanning more than a century, giving the combined business a rare legacy to build on," Skydance stated in a press release. "The aim of the combined company is to build the next-generation global media and entertainment company powered by creativity and technology."
The company's entertainment franchises span "Sopranos" to "SpongeBob SquarePants" and "Euphoria" to "Harry Potter." The portfolio also encompasses television networks CBS, CBS News, CBS Sports, CNN, TNT, TBS, Nickelodeon, and MTV, among others.

#build

John Leguizamo, the veteran stage and screen actor and leading activist for Latino representation in Hollywood, who is currently garnering career-best notices and Oscar buzz for his portrayal of Eumaeus in Christopher Nolan's The Odyssey, is our guest on this episode of The Hollywood Reporter's Awards Chatter podcast, which was recorded in front of an audience of students at Chapman University.
Over the course of 42 years in the business, Leguizamo has worked with everyone. He has been directed by Brian De Palma, Spike Lee, Baz Luhrmann and Jon Favreau multiple times, as well as by Mike Nichols, George A. Romero, Ridley Scott, Todd Haynes, M. Night Shyamalan, Ava DuVernay and Christopher Nolan. And he has shared the screen with the likes of Sean Penn, Harrison Ford, Al Pacino, Leonardo DiCaprio, Wesley Snipes, Arnold Schwarzenegger, Robert De Niro, Keanu Reeves, Nicole Kidman, Kevin Hart, Tina Fey, Amy Poehler and Matt Damon.

In the movies, he has starred in blockbuster studio franchises (Ice Age and John Wick), revered indies (Poison and Chef) and cult classics (Super Mario Bros. and To Wong Foo, Thanks for Everything! Julie Newmar). On TV, he has been on hit network shows (ER) and acclaimed limited series (Waco and When They See Us). And on the stage, he has written and starred in six acclaimed one-man shows. Between them all, he has accumulated an Emmy Award and a special Tony Award, as well as Golden Globe and Critics Choice award nominations.
More from The Hollywood Reporter
Universal Becomes First Studio to Cross $5B at 2026 Global Box Office
Charlize Theron Says 'The Odyssey' Just Gave Hollywood a Much-Needed Reminder

#hollywood

An **** ysis of recent filings from American politicians shows that Accenture (NYSE: ACN) and Boston Scientific (NYSE: BSX) saw an uptick in purchases from notable politicians. Rep. Gilbert Ray Cisneros, Jr. (D-CA) bought Boston Scientific shares, according to a filing earlier this month. The trade was made on August 18, 2026. Rep. Ro Khanna (D-CA) also bought the stock twice, on August 3 and August 10, 2026, according to a filing filed on September 4, 2026. Neither politician sold Boston Scientific shares in the same period. Cisneros and Khanna were also the two buyers of Accenture shares in July and August.
This is based on data from Quiver Quantitative, a platform that tracks congressional stock trades from politicians.
Let's focus on BSX in this article.
BSX is down about 50% so far this year amid a cyberattack that disrupted manufacturing, order processing and shipments, forcing the company to withdraw its previous third-quarter and full-year outlook. Bulls say the market has priced in too severe an outcome. By Sept. 8, the company said its major distribution centers were shipping at or above normal levels, sterilization facilities were operating, and manufacturing had restarted at most plants. Bulls believe much of the disrupted revenue could be delayed rather than permanently lost as hospitals wait for products, reschedule procedures and the company works through its backlog.
Bulls also point to a business that was still growing. Second-quarter revenue rose 7.5% year over year and organic growth was 7%. Several core franchises delivered double-digit organic growth, including Interventional Cardiology and Vascular Therapies, Interventional Oncology and Embolization, and Neuromodulation.

#august #NYSE

New York-based Take-Two Interactive Software, Inc. (TTWO) is a major global video-game publisher and developer behind some of the industry's biggest franchises, including Grand Theft Auto, Red Dead Redemption, NBA 2K, Borderlands, Civilization, WWE 2K, and Zynga's mobile games. Its business spans console, PC, and mobile gaming through three key labels: Rockstar Games, 2K, and Zynga.
Companies with a market cap between $10 billion and $200 billion are typically referred to as "large-cap stocks, and TTWO, with a market cap of $41.7 billion, fits the label. The company's biggest competitive advantage is its deep portfolio of highly recognizable intellectual property. Rockstar's Grand Theft Auto franchise alone has sold more than 470 million units, while GTA V has surpassed 230 million units sold worldwide. Moreover, Grand Theft Auto VI is scheduled for Nov. 19, 2026, alongside new installments of NBA 2K, WWE 2K, PGA TOUR 2K and other franchises.
Goldman Sachs Expects Fed Chair Kevin Warsh to Raise Rates This Week — But Not Because of Oil Prices.
Morgan Stanley Doubles Down on Apple Stock as New Offerings Become 'More Exciting'
The EV Bubble Has Burst. How to Play Rivian Stock Now.

#grand #theft #ttwo

New York-based Take-Two Interactive Software, Inc. (TTWO) is a major global video-game publisher and developer behind some of the industry's biggest franchises, including Grand Theft Auto, Red Dead Redemption, NBA 2K, Borderlands, Civilization, WWE 2K, and Zynga's mobile games. Its business spans console, PC, and mobile gaming through three key labels: Rockstar Games, 2K, and Zynga.
Companies with a market cap between $10 billion and $200 billion are typically referred to as "large-cap stocks, and TTWO, with a market cap of $41.7 billion, fits the label. The company's biggest competitive advantage is its deep portfolio of highly recognizable intellectual property. Rockstar's Grand Theft Auto franchise alone has sold more than 470 million units, while GTA V has surpassed 230 million units sold worldwide. Moreover, Grand Theft Auto VI is scheduled for Nov. 19, 2026, alongside new installments of NBA 2K, WWE 2K, PGA TOUR 2K and other franchises.
Goldman Sachs Expects Fed Chair Kevin Warsh to Raise Rates This Week — But Not Because of Oil Prices.
Morgan Stanley Doubles Down on Apple Stock as New Offerings Become 'More Exciting'
The EV Bubble Has Burst. How to Play Rivian Stock Now.

#theft #auto #Stock #biggest

An ******* ysis of recent filings from American politicians shows that Accenture (NYSE: ACN) and Boston Scientific (NYSE: BSX) saw an uptick in purchases from notable politicians. Rep. Gilbert Ray Cisneros, Jr. (D-CA) bought Boston Scientific shares, according to a filing earlier this month. The trade was made on August 18, 2026. Rep. Ro Khanna (D-CA) also bought the stock twice, on August 3 and August 10, 2026, according to a filing filed on September 4, 2026. Neither politician sold Boston Scientific shares in the same period. Cisneros and Khanna were also the two buyers of Accenture shares in July and August.
This is based on data from Quiver Quantitative, a platform that tracks congressional stock trades from politicians.
Let's focus on BSX in this article.
BSX is down about 50% so far this year amid a cyberattack that disrupted manufacturing, order processing and shipments, forcing the company to withdraw its previous third-quarter and full-year outlook. Bulls say the market has priced in too severe an outcome. By Sept. 8, the company said its major distribution centers were shipping at or above normal levels, sterilization facilities were operating, and manufacturing had restarted at most plants. Bulls believe much of the disrupted revenue could be delayed rather than permanently lost as hospitals wait for products, reschedule procedures and the company works through its backlog.
Bulls also point to a business that was still growing. Second-quarter revenue rose 7.5% year over year and organic growth was 7%. Several core franchises delivered double-digit organic growth, including Interventional Cardiology and Vascular Therapies, Interventional Oncology and Embolization, and Neuromodulation.

#accenture

The Tennessee ******* ans and New York Jets are set to begin the 2026 season with a Week 1 matchup at Nissan Stadium on Sunday.
A matchup featuring two teams looking to turn their franchises around, there isn't much of an expectation that this game is going to feature much offense to be excited about. With that said, there are a handful of names that fantasy football managers are wondering about for Sunday.
Both the ******* ans and the Jets have some major question marks on the offensive side of the ball, but value can be found anywhere throughout the league.
Here's a look at who to start and sit for fantasy football in this Week 1 matchup:
Wilson's fourth season was cut short to only seven games, but he should be a solid start in Week 1. The ******* ans allowed the third-most fantasy points per game (29.7) to the wide receiver position. Wilson has been plagued by poor quarterback play and while Geno Smith isn't a major upgrade, he's better than what they've had. Wilson should be in for some high-end WR2 numbers.

#Titans #Jets #much

Both the Steelers and the Falcons have new coaching staffs heading into Week 1. It's safe to say both franchises will be looking to start their new era off on the right foot with a victory. I spoke with Kevin Knight of The Falcoholic to learn a bit about what's new with the Atlanta Falcons.
Kevin Knight: Well, now even Tua Tagovailoa is out of the lineup thanks to an oblique injury suffered during individual drills on Thursday. That means Cooper Rush at the helm (who, in truth, may not be any worse than Tua based on the aforementioned preseason). What you're going to see is a lot of quick game, and as much Bijan Robinson as the team can muster. If Atlanta can run the ball well and get Bijan going, they can score points. So that'll be the plan, with the passing game largely taking a complementary role until Michael Penix Jr. returns.
Kevin Knight: This is a good defense that will have to find ways to manufacture pass rush. Thankfully, Jeff Ulbrich is an evil genius with his blitz packages, and he's got a lot of interesting looks planned. Expect to see a lot of linebacker and slot blitzes to supplement their weaker edge rusher room, along with a lot of emphasis on interior pass rush. Atlanta has a really nice interior duo with Brandon Dorlus (who was leading all interior defensive linemen in the NFC with 8.5 sacks last season before injury) and trade acquisition Gervon Dexter Sr. They're hoping the interior can offset some of their weaknesses outside.
Kevin Knight: I like Kevin Stefanski and think it pretty much takes a miracle worker to extract any amount of success from the Cleveland Browns organization. It does seem like there's a coherent, forward-thinking plan in place for this Falcons team for the first time in years. I don't necessarily expect a lot of success in 2026 based on the moves made to this point and the way the team is structured, but I do expect Atlanta to be one of the most aggressive teams in free agency and the draft in 2027.
Kevin Knight: As I mentioned before, Brandon Dorlus is a borderline-elite interior pass rusher who may also get some run on the edge. Linebacker Divine Deablo was the biggest surprise in last year's free agent class and completely transformed the defense when he was on the field. Second-year safety Xavier Watts was a DROY candidate in 2025 and forms a dynamic duo with veteran Jessie Bates III. Atlanta will be starting two rookies on defense: Avieon Terrell (brother of A.J. Terrell) in the slot, and Kendal Daniels at linebacker. Both impressed in training camp, with Daniels being a particularly pleasant surprise given his Day 3 selection.

#expect

One could call it chance or call it fate, but there's little doubt that it required quite a bit of good fortune for the Chicago Bears to wind up with Caleb Williams as their No. 1 quarterback. As they prepare to meet the Carolina Panthers in this weekend's season opener, the trade history of the two franchises is back in the spotlight.
The Bears famously sent the No. 1 overall pick to the Panthers back in 2023. In return, they acquired the Panthers' first and second-round picks in 2023, another first-round pick in 2024, a 2025 second-round pick, and wide receiver D.J. Moore. Moore is, of course, now in Buffalo, but mainstays in Darnell Wright, Tyrique Stevenson, and Luther Burden III remain key components of the 2026 squad.
The ability to draft Williams the following year, however, remains the most crucial part of the deal that allowed the Panthers to select Bryce Young atop that 2023 draft. The two quarterbacks enter the new season with differing development paths and outside perceptions, but Williams, for his part, expressed gratitude over how things materialized.

#round

On August 27, AstraZeneca PLC (NYSE:AZN) and Amgen Inc. (NASDAQ:AMGN) scored a shared clinical victory. Positive high-level results from the Phase III CROSSING trial showed that their co-developed severe asthma drug, TEZSPIRE, achieved statistically significant and clinically meaningful improvements across both co-primary endpoints, histologic remission and the frequency/severity of dysphagia, and all key secondary endpoints at week 24 in patients with eosinophilic esophagitis. These benefits were sustained through week 52 across both tested doses, accompanied by a safety profile consistent with its approved indications. While CROSSING highlights their joint R&D success, a closer look at their standalone financial performance reveals distinct growth trajectories.
Both pharmaceutical giants delivered solid Q2 2026 results, but AstraZeneca is showing stronger overall financial momentum. AstraZeneca PLC (NYSE:AZN)'s Q2 revenue increased 6% year over year to $15.38 billion, supported by its Oncology franchise, which grew 18% in H1 to $14.12 billion, and its Rare Disease portfolio, which increased 13%. Core EPS rose 21% to $2.63, beating expectations, while management reaffirmed its full-year 2026 outlook for mid-to-high single-digit revenue growth and low double-digit Core EPS growth.
Amgen Inc. (NASDAQ:AMGN) reported Q2 revenue of $10.1 billion, up 10% year over year, while non-GAAP EPS increased 4% to $6.29. Although its key growth products advanced 26%, mature products faced significant biosimilar pressure, with Prolia revenue declining 32% and XGEVA falling 34%. Amgen nevertheless raised its 2026 revenue guidance midpoint to $39.4 billion.
Overall, AZN holds the financial edge due to stronger EPS growth, broader portfolio momentum, and less exposure to the biosimilar erosion affecting AMGN's mature products.
Amgen's bull case is supported by robust growth in key products, which increased 26%, and $3.5 billion in Q2 free cash flow, providing substantial capital flexibility. Wells Fargo raised its Amgen price target to $435 from $400 on September 4, citing potential upside from HORIZON and pipeline ****** ets such as olpasiran. New Phase III VESALIUS-CV data also showed Repatha reduced the risk of death by 20% in high-risk adults without a prior heart attack or stroke, with heart attack risk reductions emerging as early as six months. However, accelerating biosimilar competition affecting legacy franchises such as Prolia and XGEVA remains a key risk to sustained margin expansion.

#revenue #astrazeneca #increased #products

On September 3, AbbVie Inc. (NYSE:ABBV) finalized its acquisition of clinical-stage biotech Apogee Therapeutics, Inc. (NASDAQ:APGE) for $135.11 per share in cash. The $10.9 billion buyouts immediately fold Apogee's promising inflammatory and immunology (I&I) pipeline into AbbVie's commercial engine. On the exact same day, AbbVie separately reported positive Phase 3 Cervino trial results for its bispecific T-cell engager, etentamig, in relapsed/refractory multiple myeloma. Together, the dual catalysts emphasize how mega-cap pharmaceutical giants are deploying cash flow from legacy franchises to lock in next-generation immunology and oncology ***** ets.
In Q2 2026, AbbVie Inc. (NYSE:ABBV) posted $16.99 billion in net revenue, up 10.2% year over year, while adjusted diluted EPS increased 22.9% to $3.65. Growth was driven by its immunology blockbusters, Skyrizi and Rinvoq, which generated $5.505 billion and $2.525 billion in revenue, respectively, representing growth of 24.4% and 24.5%. These gains more than offset the continued decline in Humira revenue, which fell 35.9% to $756 million amid biosimilar competition. AbbVie reiterated its full-year 2026 adjusted EPS guidance of $13.87–$14.07, including a $0.14 dilutive impact from the Apogee transaction.
As a clinical-stage biotech, Apogee Therapeutics, Inc. (NASDAQ:APGE) generated no product revenue in Q2 2026, while R&D expenses reached $67.3 million and G&A expenses totaled $24.3 million, resulting in a quarterly net loss of $85.9 million. Despite the cash burn, the company maintained a strong liquidity position, with $1.3 billion in cash and marketable securities, alongside a $1.3 billion non-dilutive credit collaboration with Blackstone Life Sciences to support Phase 3 trials of its lead ***** et, zumilokibart.
Financially, AbbVie is vastly superior in immediate cash generation and profitability, whereas Apogee represented pure clinical optionality backed by robust liquidity.
For AbbVie, acquiring Apogee's optimized antibody portfolio, including zumilokibart for atopic dermatitis, strengthens its post-Humira immunology franchise. Combined with internal R&D advances such as etentamig, which achieved statistically significant overall response rate and progression-free survival results in the Phase 3 Cervino study, along with an 87.9% 12-month overall survival rate, AbbVie demonstrates potential to sustain strong organic growth.

#phase #revenue #Growth

Our ***** ysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.
Management attributes the sequential improvement in comparable sales to enhanced digital conversion and the successful scaling of private brand franchises like THERMACHILL.
The company is navigating a structural shift in customer behavior driven by GLP-1 medication adoption, which has led to temporary pauses in apparel purchasing during weight loss journeys.
Performance was significantly bolstered by a $4.6 million IEEPA tariff refund, which masked a 70 basis point decline in underlying merchandise margins caused by higher markdowns and shipping surcharges.
Strategic focus has shifted toward 'Fit Authority' through the FITMAP initiative, which has scanned 150,000 customers and resulted in higher average order values and lower return rates.

#performance

Stephon Castle showcases his gratitude for the Spurs legends' impactful support originally appeared on The Sporting News. Add The Sporting News as a Preferred Source by clicking here.
Across the NBA, there are plenty of iconic franchises. One of them is the San Antonio Spurs, a team with a history of success. They have won five championships in their time in the NBA, and their legends continue to stick around and help the next generation.
People like Tim Duncan, Manu Ginobili, David Robinson, and many more are always present for the Spurs. This has helped the younger players because they know that they have some mentors to go to when they need help.
For any Spurs player, they will become familiar with the older figures within the organization who have been there for a long time. Of course, Gregg Popovich is probably the most recognizable one, as he is still the team president.
Mitch Johnson might have taken over as the head coach, but Pop still has an impact and influence on the players. Youngsters like Castle and Dylan Harper are benefiting from this because they know they have mentors to look up to.

#sporting #team #Help

A longtime NBA journeyman recently named Golden State Warriors point guard Stephen Curry as one of the league's top five players. In an interview with HoopsHype, 14-year NBA veteran Danilo Gallinari spoke about his career and the current state of the NBA. When asked to give a top-five list of current players, Curry was the first name he said. "Current Top 5, I always, I guess I always go with the old heads first: Stephen Curry, Kevin Durant, and LeBron James. And then I put Anthony Edwards and Nikola Jokic."
Gallinari, a former No. 6 overall pick in the 2008 NBA Draft, played for eight different franchises, with his longest stop coming in Denver. Despite suffering two ACL tears during his career, the Italian forward put together an impressive resume, playing in 777 career games, averaging 14.9 points, 4.7 rebounds, 1.9 ***** ists and 0.7 steals while shooting 42.8% from the floor and 38.1% from beyond the arc. His strongest campaign came with the Los Angeles Clippers during the 2018-19 season, where he averaged 19.8 points, 6.1 rebounds, 2.6 ***** ists and 0.7 steals. Gallinari's final season came during the 2023-24 campaign, where he played for three different teams, the Wizards, Pistons and Bucks.
For more NBA content, check out the BasketBaltes podcast:
https://www.youtube.com/@B...
https://www.instagram.com/...

#current #first

The International League T20 (ILT20) Season 5 was officially launched with a glittering event in Dubai, with fast-bowling legends Brett Lee and Shoaib Akhtar among the star attractions on an evening celebrating the league's rapid rise and growing influence across the Gulf region.

The event brought together leading figures from cricket, sport, business and government, with ILT20 chairman Khalid Al Zarooni and league commissioner, ICC board director and ECB general secretary Mubashshir Usmani highlighting the tournament's contribution to the development and expansion of cricket in the UAE and the wider region.

Al Zarooni reflected on the league's growth while thanking its stakeholders and partners.

"What began as a dream has grown into one of the world's leading cricket leagues, bringing together top players and major franchises, while helping grow cricket in the UAE, the region and beyond," he said.

He also acknowledged the support of franchise owners, commercial and strategic partners, with a special mention for Zee Network, while welcoming SPORTFIVE as a new commercial partner.
A special panel discussion hosted by former New Zealand international Simon Doull explored the changing landscape and future of cricket in the region and globally.

The panel featured Usmani, Dr Mohamed Abu Hamra, Eisa Sharif of the Dubai Sports Council, ZEE Entertainment Enterprises Deputy CEO and CFO Mukund Galgali, SportFive President Venu Nair and Bisleri Global Director Sales & Marketing Tushar Malhotra.

Doull later brought Lee and Shoaib together for another engaging discussion, with the two legendary fast bowlers speaking about the ILT20's growing impact on UAE and regional cricket.

The pair also looked back on their playing careers, recalling an era in which their blistering pace made them two of the most feared fast bowlers in world cricket.

The evening also featured a spell-binding performance by celebrity mentalist Karan Singh Magic, while the league unveiled its new brand identity for Season 5.
Season 5 will be played in November and December across the UAE's three iconic venues — Zayed Cricket Stadium in Abu Dhabi, Dubai International Stadium and Sharjah Cricket Stadium.

Defending champions Desert Vipers will enter the fifth season aiming to retain their crown. Gulf Giants won the inaugural season, followed by MI Emirates in Season 2 and Dubai Capitals in Season 3.

#stadium

If you hold Pfizer (PFE) or Zoetis (ZTS), you hold the same idea: a branded medicine becomes a standard of care and keeps earning for years, in people or in animals. That is where it stops. Pfizer is buying replacements for older drugs losing exclusivity. Zoetis is cutting its effective price to keep the franchises it has. Same bet, two opposite defenses.
Pfizer lifted the midpoint of its 2026 revenue guidance by $500 million while cutting its COVID-19 revenue expectation to about $4 billion from about $5 billion. The rest of the company covered that gap: excluding COVID products, the underlying business grew 5% operationally in the second quarter of 2026, with Eliquis and Padcev among the drivers management named.
Zoetis cut its 2026 outlook and now expects revenue to decline 1% to 3% on an organic operational basis. Management said sales trends through July had not yet indicated market stabilization. Pfizer's raise rests on business it can already see. Zoetis has yet to see visibility on market stabilization.
Pfizer is buying growth and cutting cost, and expects about $9.7 billion in total net savings through 2029. What that funds is an aim, not a guide: a risk-adjusted high single-digit revenue CAGR from year-end 2028 through year-end 2033.
The pipeline behind that aim is expensive to get wrong. A Phase III lung cancer trial that missed its primary endpoint and, to a lesser extent, the removal of revenue projections for Oxbryta led to $4.3 billion of noncash intangible **** et impairments recorded in the second quarter of 2026. While an unadjusted price-to-EBIT comparison puts Pfizer at 23.9 against Zoetis at 9.2, aligning the two on operating income brings them to 9.7x and 9.0x, largely erasing the paying-up premium.

#pfizer #covid

Cricket Australia (CA) has opened the door to private investment in the Big Bash League (BBL), with the Melbourne Renegades set to become the first franchise offered for sale from the 2027-28 season.

The decision comes after months of discussions between Cricket Australia and Australia's state cricket ***** ociations over the future of the domestic T20 competition.

At a press conference at the SCG on Tuesday afternoon, CA confirmed that the Renegades will be the first BBL franchise to enter the private ownership process. Other BBL and WBBL teams could also be offered for sale in the future under a "self-determination" model.

The governing body said the move is aimed at bringing private investment into the T20 competition and strengthening the financial position of Australian cricket as players and teams are increasingly being drawn towards lucrative leagues around the world.

"CA will invite bids from private owners for the Renegades with a view to them playing the 2027-28 season under new ownership," the governing body said in a statement on Tuesday.

"Beginning the sales process for the Renegades allows us to take the first step in a self-determination model for our members and represents a defining moment for the game," said Cricket Australia chair Mike Baird.

"This is a significant decision that has involved an enormous amount of ***** ysis, discussion and collaboration over many months."

CA said other franchises could be put on the market at a later stage.

"Pending the result of that process, CA will consider taking other clubs to market under a self-determination model that gives each state member the ability to ***** s the optimal pathway for its own club and community."

According to cricket.com.au, Hobart Hurricanes, Perth Scorchers and Melbourne Stars are among the other clubs believed to be interested in private investment.

The Renegades are owned by Cricket Victoria, which supported CA's original plan. They won the BBL ***** le in the 2018-19 season.

The move comes as CA looks to strengthen its finances. Despite a boost in revenue from hosting a five-Test series against India, the game's biggest financial market, CA reported a net deficit of A$11.3 million for the 2024-25 financial year.

"By opening the door to private investment in the Big Bash Leagues, Cricket Australia is taking a deliberate step to strengthen and secure the long-term future of the game," CA Chairman Mike Baird said in Tuesday's statement.

Australia Prime Minister Anthony Albanese announced in July that December's BBL 2026-27 season opener between the Renegades and Perth Scorchers would take place in the Chennai.

While CA is allowing private ownership, it will continue to control key areas of the competition. Baird said the governing body will retain control over international scheduling, player availability, salary caps and media rights.

CA will also have the power to approve or veto investors and set a reserve price for

To cap off Week 1 of the NFL season, on Monday evening, the Kansas City Chiefs will host the Denver Broncos for a "Monday Night Football" bout at Arrowhead Stadium in Kansas City, Missouri. Kickoff is scheduled for 7:15 p.m. The game will be broadcast nationally on ABC and ESPN.
According to FanDuel Sportsbook, Kansas City begins the week as a 2.5-point favorite.
The last time these two franchises faced off was Christmas Day at Arrowhead; Denver closed as a 13.5-point favorite against the Chiefs without quarterback Patrick Mahomes. Kansas City covered, but the Broncos pulled away from a tie game in the fourth quarter to win 20-13.
Of course, Denver's victory sealed the clean sweep of the Chiefs in 2025: in Week 11, the Chiefs were four-point favorites on the road against the Broncos, but lost 22-19.
In the 2026 preseason, the Chiefs were defeated by the Los Angeles Rams, Tampa Bay Buccaneers and Seattle Seahawks. The Broncos beat the Atlanta Falcons and Minnesota Vikings, but lost to the Green Bay Packers.

#chiefs #point #Monday #denver

Texas billionaire Dan Friedkin and The Friedkin Group (TFG) seem to be intently
focused on spinning multiple business deals involving sports franchises across two continents, whether to buy or sell.
Negotiations are currently underway between TFG, a prominent player in global sports investment that manages its multi-club portfolio through its Houston-based division, Pursuit Sports, and representatives from Houston and Austin. The group is awaiting agreement on terms and the approval of the NHL Board of Governors to establish a team in either city by the end of 2026.
But now Friedkin has another move in play, potentially selling a minority stake in Everton Football Club in the English Premier League. According to The Athletic, the idea is to find strategic investors who can help push the club forward.
However, a former Everton top executive believes that a full sale of the club is on the table, given the recent struggles to appease supporters and a catastrophic summer transfer window in which multiple top players left while the club acquired undesirable players in return.

#club #everton #multiple

Our ******* ysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.
Performance was driven by a recovery in U.S. e-commerce following the resolution of warehouse management system (WMS) issues that had previously disrupted shipments.
Management prioritized high-margin sales and brand integrity over promotional volume in third-party marketplaces, resulting in a 500 basis point gross margin improvement despite lower revenue.
New customer acquisition was fueled by 'iconic' franchises, specifically totes and swim, which served as entry points for younger demographics and new-to-brand shoppers.
The Europe business pivoted toward a 'franchise-first' ******* ortment to simplify operations and improve product margins, resulting in flat revenue but enhanced profitability.

#Margin #brand #performance #Europe

Artisan Partners, an investment management company, released its second-quarter 2026 investor commentary for the "Artisan Global Opportunities Strategy". The letter can be downloaded here. Global equities rebounded sharply during the quarter, with the MSCI ACWI Index returning 15.3% as resilient economic growth, strong corporate earnings, and continued enthusiasm around artificial intelligence supported markets despite persistent inflation, higher bond yields, and geopolitical uncertainty. The portfolio reported strong absolute returns of 12.65% (net) but underperformed the benchmark, mainly because of its underweight exposure to information technology and overweight position in health care. Strong stock selection in technology and energy partially offset these headwinds. The fund continues to see attractive long-term opportunities across AI infrastructure, health care and consumer internet, while remaining disciplined on valuation as several AI-related stocks have appreciated sharply. Management remains focused on durable franchises with identifiable profit cycles and attractive long-term earnings potential. Also, check the Strategy's top five holdings to see its best picks in 2026.
In its second-quarter 2026 investor letter, Artisan Global Opportunities Strategy highlighted Insmed Incorporated (NASDAQ:INSM). Insmed Incorporated (NASDAQ:INSM) is a clinical-stage biotechnology company that develops and commercializes therapies for patients with serious and rare diseases. On September 01, 2026, Insmed Incorporated (NASDAQ:INSM) closed at $121.51 per share. Over the past month, Insmed Incorporated (NASDAQ:INSM) returned 25.42%, and its shares lost 13.45% over the past 52 weeks. Insmed Incorporated (NASDAQ:INSM) has a market capitalization of $27.14 billion.
Artisan Global Opportunities Strategy stated the following regarding Insmed Incorporated (NASDAQ:INSM) in its Q2 2026 investor letter:
"Our biggest detractors in Q2 were Insmed Incorporated (NASDAQ:INSM), BAE Systems and L3Harris Technologies. Insmed is a commercial-stage biotechnology company focused on pulmonary diseases. BRINSUPRI® continued its rapid launch, with robust patient uptake and encouraging third-party data. While Q1 sales came in modestly below elevated investor expectations, reflecting concerns around discontinuation rates, continuation on therapy and typical early-year seasonality, we believe the underlying launch trajectory remains encouraging. We continue to view BRINSUPRI® as a significant long-term opportunity. Our due diligence suggests the therapy remains well tolerated and is on track to achieve blockbuster-level sales. We trimmed the position during the quarter."

#NASDAQ #global #quarter

Artisan Partners, an investment management company, released its second-quarter 2026 investor commentary for the "Artisan Global Opportunities Strategy". The letter can be downloaded here. Global equities rebounded sharply during the quarter, with the MSCI ACWI Index returning 15.3% as resilient economic growth, strong corporate earnings, and continued enthusiasm around artificial intelligence supported markets despite persistent inflation, higher bond yields, and geopolitical uncertainty. The portfolio reported strong absolute returns of 12.65% (net) but underperformed the benchmark, mainly because of its underweight exposure to information technology and overweight position in health care. Strong stock selection in technology and energy partially offset these headwinds. The fund continues to see attractive long-term opportunities across AI infrastructure, health care and consumer internet, while remaining disciplined on valuation as several AI-related stocks have appreciated sharply. Management remains focused on durable franchises with identifiable profit cycles and attractive long-term earnings potential. Also, check the Strategy's top five holdings to see its best picks in 2026.
In its second-quarter 2026 investor letter, Artisan Global Opportunities Fund highlighted L3Harris Technologies, Inc. (NYSE:LHX). L3Harris Technologies, Inc. (NYSE:LHX) provides mission-critical solutions for government and commercial customers worldwide. On September 01, 2026, L3Harris Technologies, Inc. (NYSE:LHX) closed at $263.56 per share. Over the past month, L3Harris Technologies, Inc. (NYSE:LHX) declined 8.44%, and its shares lost 4.08% over the past 52 weeks. L3Harris Technologies, Inc. (NYSE:LHX) has a market capitalization of $48.76 billion.
Artisan Global Opportunities Fund stated the following regarding L3Harris Technologies, Inc. (NYSE:LHX) in its Q2 2026 investor letter:
"L3Harris Technologies, Inc. (NYSE:LHX) is a global aerospace and defense company that we believe remains well positioned to benefit from growing investment in next-generation missile defense, ****** e sensing and national security programs. Recent results exceeded expectations, with 15% organic growth driven by continued strength in its ****** e and mission systems and missile solutions segments. Order activity remained healthy, with backlog reaching $41 billion and international demand accelerating. Despite the solid operating performance, shares declined amid concerns over future competition and the potential implications for long-term market share. While strong bookings and accelerating revenue continue to support our long-term investment thesis, we began harvesting the position as we reallocated capital within the industrials sector."

#global #artisan #opportunities

Artisan Partners, an investment management company, released its second-quarter 2026 investor commentary for the "Artisan Global Opportunities Strategy". The letter can be downloaded here. Global equities rebounded sharply during the quarter, with the MSCI ACWI Index returning 15.3% as resilient economic growth, strong corporate earnings, and continued enthusiasm around artificial intelligence supported markets despite persistent inflation, higher bond yields, and geopolitical uncertainty. The portfolio reported strong absolute returns of 12.65% (net) but underperformed the benchmark, mainly because of its underweight exposure to information technology and overweight position in health care. Strong stock selection in technology and energy partially offset these headwinds. The fund continues to see attractive long-term opportunities across AI infrastructure, health care and consumer internet, while remaining disciplined on valuation as several AI-related stocks have appreciated sharply. Management remains focused on durable franchises with identifiable profit cycles and attractive long-term earnings potential. Also, check the Strategy's top five holdings to see its best picks in 2026.
In its second-quarter 2026 investor letter, Artisan Global Opportunities Strategy highlighted Robinhood Markets, Inc. (NASDAQ:HOOD) as a new holding. Robinhood Markets, Inc. (NASDAQ:HOOD) is a US-based financial services company that provides a trading platform for stocks, exchange-traded funds, American depository receipts, options, gold, and cryptocurrencies. On September 01, 2026, Robinhood Markets, Inc. (NASDAQ:HOOD) closed at $103.51 per share. Robinhood Markets, Inc. (NASDAQ:HOOD) returned 14.18% over the past month and its shares have gained 5.10% over the past 52 weeks. Robinhood Markets, Inc. (NASDAQ:HOOD) has a market capitalization of $93.06 billion.
Artisan Global Opportunities Strategy stated the following regarding Robinhood Markets, Inc. (NASDAQ:HOOD) in its Q2 2026 investor letter:
"During the quarter, we initiated positions in Robinhood Markets, Inc. (NASDAQ:HOOD). Robinhood Markets operates a financial services platform offering brokerage, cash management and other investing products. We initiated a GardenSM position following share price weakness driven in part by lower crypto prices, which we viewed as an attractive entry point into a business with a long runway for growth. Despite the crypto headwind, Robinhood has continued to grow deposits at a strong rate, reflecting the platform's ability to attract and retain customer ***** ets. We believe Robinhood can continue gaining market share in the retail wealth market through its leadership in active trading and by expanding its suite of retirement, banking, lending and credit products. As the company has gained market share and increased its base of long-term customer ***** ets, we see a multiyear opportunity for potential revenue growth and margin expansion."

#opportunities #strong #strategy